New research links ether-lipid accumulation to hepatocellular carcinoma progression, revealing metabolic pathways that may drive tumor growth. Separately, non-coding RNAs have been shown to influence cancer cell response to Topotecan chemotherapy. These findings improve understanding of liver cancer biology and could inform future targeted therapeutic approaches, emphasizing the complexity of tumor metabolism and gene regulation.